| (210) | Number of the EPO application | 19182383 |
| (220) | Filing date of the EPO application | 2015.11.26 |
| (80) | EPO patent specification publication (B) | EPB nr. 52/2020, 2020.12.23 |
| (110) | EPO patent number | 3567037 |
| (11) | Number of the document | MD 3567037 T2 |
| (21) | Number of the application | e 2019 1295 |
| (71) | Name(s) of applicant(s), code of the country | Kalvista Pharmaceuticals Limited, GB; |
| (72) | Name(s) of inventor(s), code of the country | DAVIE Rebecca Louise, GB;
EDWARDS Hannah Joy, GB;
EVANS David Michael, GB;
HODGSON Simon Teanby, GB; |
| (73) | Name(s) of owner(s), code of the country | KALVISTA PHARMACEUTICALS LIMITED, GB; |
| (54) | Title of the invention | N-((het)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 401/14 (2006.01.01); C07D 413/14 (2006.01.01); A61K 31/415 (2006.01.01); A61K 31/454 (2006.01.01); A61K 31/4709 (2006.01.01); A61K 31/497 (2006.01.01); A61K 31/506 (2006.01.01); C07D 231/14 (2006.01.01); C07D 401/06 (2006.01.01); C07D 401/10 (2006.01.01); C07D 403/10 (2006.01.01); C07D 409/14 (2006.01.01) |
| (19) | Country | GB |
| (41) | Date of publication of the application | 2019.12.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.05.31 |
| (30) | Priority | 201421083, 2014.11.27, GB |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |